Postmenopausal hormone therapy and the risk of breast cancer: A clinician’s view
✍ Scribed by Leon Speroff
- Book ID
- 116731229
- Publisher
- Elsevier Science
- Year
- 2004
- Tongue
- English
- Weight
- 68 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0378-5122
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Epidemiological studies indicate that menopausal estrogen‐progestin therapy (EPT) use is associated with an increase in breast cancer risk. Further data are needed on whether this association varies by specific prognostic factors and ethnicity. We conducted a cohort study among 55,371 A
## Abstract Hormone therapy (HT) and body mass index (BMI) have been associated with postmenopausal breast cancer. Because estrogen metabolism may affect breast cancer risk and can be altered by weight and HT, it might play a role in the HT–BMI–breast cancer associations. We undertook a nested case